Company
Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.
Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. has 1 drug tracked on RxWires: 1 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| HW281171 tablets | Phase 1 | Chronic Urticaria |
Latest
No recent events.
Follow Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.